C-reactive protein haplotype is associated with high PSA as a marker of metastatic prostate cancer but not with overall cancer risk

C Eklund; T Tammela; J Schleutker; M Hurme

doi:10.1038/sj.bjc.6605081

C-reactive protein haplotype is associated with high PSA as a marker of metastatic prostate cancer but not with overall cancer risk

C Eklund
, T Tammela
, J Schleutker
, M Hurme

Research output: Contribution to journal › Article › Scientific › peer-review

11 Citations (Scopus)

Original language	English
Pages (from-to)	1846-1851
Journal	British Journal of Cancer
Volume	100
Issue number	12
DOIs	https://doi.org/10.1038/sj.bjc.6605081
Publication status	Published - 2009
Publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

CRP gene
association study
immunology
inflammation
prostate cancer

Access to Document

10.1038/sj.bjc.6605081

Cite this

@article{40f734c1f5504d4ea956f93beadf9160,

title = "C-reactive protein haplotype is associated with high PSA as a marker of metastatic prostate cancer but not with overall cancer risk",

keywords = "CRP gene, association study, immunology, inflammation, prostate cancer, CRP gene, association study, immunology, inflammation, prostate cancer",

author = "C Eklund and T Tammela and J Schleutker and M Hurme",

year = "2009",

doi = "10.1038/sj.bjc.6605081",

language = "English",

volume = "100",

pages = "1846--1851",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Springer Nature",

number = "12",

}

TY - JOUR

T1 - C-reactive protein haplotype is associated with high PSA as a marker of metastatic prostate cancer but not with overall cancer risk

AU - Eklund, C

AU - Tammela, T

AU - Schleutker, J

AU - Hurme, M

PY - 2009

Y1 - 2009

KW - CRP gene

KW - association study

KW - immunology

KW - inflammation

KW - prostate cancer

KW - CRP gene

KW - association study

KW - immunology

KW - inflammation

KW - prostate cancer

U2 - 10.1038/sj.bjc.6605081

DO - 10.1038/sj.bjc.6605081

M3 - Article

SN - 0007-0920

VL - 100

SP - 1846

EP - 1851

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 12

ER -